Improve your probability of success in a fast, cost-efficient way

Pain Cloud® is a novel digital solution, designed to increase the probability of success for analgesic clinical development, creating significant savings in project timelines and costs.

Improve your probability of success in a fast, cost-efficient way

Pain Cloud® is a novel digital solution, designed to increase the probability of success for analgesic clinical development, creating significant savings in project timelines and costs.

Improve your probability of success in a fast, cost-efficient way

Pain Cloud® is a novel digital solution, designed to increase the probability of success for analgesic clinical development, creating significant savings in project timelines and costs.

Built by EptivA Therapeutics, Pain Cloud® can be used in all stages of development from research to clinical stage projects. It enables the identification of novel applications for existing medicines, creating market extension and room for repurposing opportunities.

Using the Personalized Analgesics® in-silico network biology research and our proprietary Pain Landscape® database of over 1,000 pain related diseases, Pain Cloud® is designed to help you match targets to the optimal pain group.

Early Research

Our Personalized Analgesics research platform brings together a network of databases linking drug targets and genetic and biological pathways to pain-related diseases.

Clinical Development

Our novel network biology approach to research, connected to our proprietary Pain Landscape database of 100s of diseases, allows us to link research targets, de-risk R&D and make significant progress towards improving the clinical development processes.

Market Extension

This enables market extension, accurately matching the mechanisms of current pain medicines to new conditions and presenting the opportunity to identify new clinical project opportunities.

Innovative Repurposing

Pain Cloud’s technology presents opportunities to repurpose existing medicines for other conditions by identifying disease associations to novel pain conditions.

The problem with traditional pain R&D

Standard pain R&D practices rely heavily on non-translatable pre-clinical models and clinical development in market-size-determined patient groups, meaning many groups of pain patients are ignored.

Find out the key reasons here:

Over-reliance on pre-clinical models

Time-consuming

Cost-intensive

99% of new analgesics fail

Focus on a limited number of pain diseases with regulatory pathway

Over-reliance on pre-clinical models

Time-consuming

Cost-intensive

99% of new analgesics fail

Focus on a limited number of pain diseases with regulatory pathway

Our solutions

The Pain Cloud B2B platform, created by EptivA Therapeutics, uses the first precision medicine approach to pain, creating more effective treatments, increasing clinical success and reducing costs. 

Explore our solutions

Find out more

Explore our articles and resources below for more information on Pain Cloud.

Oct 03 2024

The Future of Pain Management: Personalized Medicine

Personalized Medicine has the potential to change everything about the way that treatment is developed and researched and in analgesics, it could lead to a wave of new...
Read More
Sep 11 2024

The Benefits of Drug Repurposing and How Pain Cloud® Can Help

Around 20% of the US population1 experience chronic pain and 8% of US adults report ‘high-impact’ chronic pain2. Estimates suggest that other Western countries report...
Read More
Aug 19 2024

Why New Analgesics Fail: Patient Stratification

Pain R&D forms the foundations for the entire pain management process, with these initial decisions key to whether pain treatments succeed or fail. The truth is,...
Read More
Aug 09 2024

EptivA present PainCLOUD® at the International Association for the Study of Pain (IASP) World Congress 2024 Amsterdam

Late Breaking Poster Presentation - #TH408 TITLE: PainCLOUD® - A Novel in-silico Network Biology Methodology to Develop Personalized Analgesics®. PRESENTER: Mark J....
Read More
Aug 02 2024

Why is Pain Research and Development So Expensive?

In this article, we will explore why pain research is so expensive, and how our B2B platform, Pain Cloud®, can help to reduce these costs, paving the way for a brighter...
Read More
Jul 03 2024

How Pain Cloud® Tackles the Challenges of Target Validation

Did you know that one in four people worldwide are suffering from chronic pain? Read on to find out how our B2B platform, Pain Cloud®, can help you improve your POS...
Read More
Jun 11 2024

Pain Cloud® Launch: A Collaboration between EptivA and Infopoly Ltd., creating an advanced solution to Pain Research.

It has been over a decade since the last new chronic pain medicine was approved by regulators, even though 1.5 billion people currently suffer chronic pain worldwide....
Read More
Jun 06 2024

Pain Cloud at IASP World Congress on Pain

We're pleased to announce that EptivA Therapeutics Ltd's 'Late Breaking Poster Submission' has been accepted for presentation at the IASP World Congress on Pain, taking...
Read More
Jun 01 2024

Pain Cloud’s new website is now live

EptivA Therapeutics Ltd. is pleased to announce that the new Pain Cloud® website is now live! We have been working hard behind the scenes to create this new channel to...
Read More
See our Blog

Inbound tracking

Keep track of your Pay-Per-Click advertising sources with our inbound tracking.

Email integrations

Send automated messages through our integration with Mailchimp.

ROI indicator

Our ROI indicator will help you understand the value you are getting from the portals you use.

Team insights

Track the performance of your team with our team insights.

Live management reporting

Our live management reporting gives you great analysis, including how many of your leads have been contacted and how quickly at a glance.

Scoring and leaderboards

Our scoring measures the speed and success of your response to incoming leads.

Statistics dashboard

We provide real-time analysis through our statistics dashboard.

Missed enquiry alerts

We notify you by email if your response times aren’t meeting company standard.

Branded auto responders - email/SMS*

Ensure your customers enquiries are acknowledged using our configureable auto responders.

*Additional SMS charges apply

Branded lead qualifier

Qualify your tenant leads before making contact. We can even help you identify student enquiries.

Lead assign

Any easy way for Branch Managers to assign leads to their team.

Enquiry type identified

We identify your leads for you including: buyers, sellers, valuation opportunities, tenants, landlords, investors and many more.

Internal messenger

To guarantee they have been read, send referals or messages to your colleagues through Callwell.

Full contact history

Recording all your call outcomes through Callwell means all your history is in one place.

Manual call back

If you miss an instant call, you can make manual calls to your customers through the Callwell system.

All your leads in one place

Our dashboard shows all your leads from all your sources in one place an instant call to your branch for new enquiries, asking your agents to "Press 1" to initiate an immediate call to the customer. We can also schedule overnight and weekend leads to call your branch when it next opens.

Instant and scheduled calls

We generate an instant call to your branch for new enquiries, asking your agents to "Press 1" to initiate an immediate call to the customer. We can also schedule overnight and weekend leads to call your branch when it next opens.